Specialities

Specialities

Alzheimer's Disease and Dementia
Brain Trauma
COVID-19
Epilepsy
Headache Disorders
Neurodegenerative Diseases
Movement Disorders
Multiple Sclerosis
Neuroimmunology
Neurological Oncology
Neurometabolic Disease
Neuromuscular Diseases
Neuropathic Pain
Stroke
Neurosurgery
Paediatric Neurology
Parkinson's Disease
Psychiatric Disorders
Rare Diseases
Sleep Disorders
Central Nervous Disorders
Neuroradiology
Search

Trending Topic

Motor neuron synapses with muscle fiber via electrical impulse transmission and neurotransmitter release, forming neuromuscular junctions , motor neuron, neuroscience
15 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

SOD1-ALS from Gene Discovery to Targeted Therapeutics: A Comprehensive Review

Joshua Newman, Phillipe Corcia, Angela Genge

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder of upper and lower motor neurons that results in progressive motor impairment. ALS is the most common disease of motor neurons with an annual incidence of approximately 1.7–2.5 per 100,000 people. It is a terminal condition with a typical life expectancy of 2–5 years from symptom onset. […]

touchREVIEWS in Neurology. 2025;21(1):1–5:Online ahead of journal publication

Connect With Us:

Facebook
X (Twitter)
Instagram
Youtube
Linkedin

Search Results

Showing Results for glycated serum proteins

Speciality Filter

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
Mark CompleteCompleted
BookmarkBookmarked

Elevation of Serum Oncostatin M Level in Acute Ischaemic Stroke: A Review

Michael Christian, Youdong Wei

Introduction The term 'stroke' is used to describe an adverse clinical state involving interference of blood circulation to the brain due to obstruction or rupture of blood vessels.1 Stroke was previously categorized into a cardiovascular disorder until the release of ...

touchREVIEWS in Neurology. 2024;20(1):33-36
Mark CompleteCompleted
BookmarkBookmarked

Societal Burden and Persisting Unmet Needs of Parkinson’s Disease

The burdens of Parkinson’s disease (PD) are undeniably serious and increasing while various unmet needs remain, especially the absence of disease-modifying therapies and the difficulty of finding new treatments that are effective in patients.1–7 Although this seems a discouraging ...

European Neurological Review. 2019:14(1):28–35. DOI: https://doi.org/10.17925/ENR.2019.14.1.28

Latest articles videos and clinical updates - straight to your inbox

Close Popup